Veeva Systems

Survey: 97% of companies to increase use of real-world patient data

Tuesday, November 14, 2017

The volume and diversity of data sources used in clinical trials are expected to increase significantly over the next three years, according to new research from Tufts Center for the Study of Drug Development. In the second report from the 2017 eClinical Landscape Study, one of the largest, most in-depth surveys of clinical data management professionals, 97% of companies say they will increase use of at least one clinical data source to make faster, more accurate decisions during trials. However, 98% of respondents currently report challenges with their clinical data management systems, indicating that companies will need to be better prepared to collect and analyze the growing volume of real-world patient data available from a variety of sources.

[Read More]

Veeva Systems launches Veeva Oncology Link

Thursday, October 26, 2017

Veeva Systems announced Veeva Oncology Link, an enterprise data solution to centralize insights and intelligence on scientific leaders in oncology. Veeva Oncology Link consolidates thousands of global experts and millions of activities—including publications, clinical trials, and events—in a single, complete source of oncology data. Now, medical affairs and commercial organizations can better plan and engage top industry thought leaders and create deeper relationships with the global oncology community.

[Read More]

Changes needed for EDC to show true efficiency

Monday, October 2, 2017

Three quarters of clinical trial managers report challenges loading data into their EDC systems, which in turn increases the time it takes to build study databases and then delays trials.
Eighty-three percent of life sciences organizations release a clinical database after the first patient, first visit. It takes an average of 68 days to build and release a clinical study database, which contributes to an increase of nearly a month downstream in the completion of a trial.

[Read More]

Survey: Universal CRO need to have unified clinical model

Wednesday, September 6, 2017

According to a global industry survey from Veeva Systems, CROs are leading an industry-wide shift to modernize clinical systems and streamline end-to-end trial processes. The Veeva 2017 Unified Clinical Operations Survey: CRO Report reveals that CROs are making progress in moving away from manual processes and legacy systems and increasingly adopting purpose-built clinical applications. However, all CROs surveyed report the need to unify their clinical applications, including their CTMS, EDC, and eTMF, to speed study execution, reduce cost and improve study quality.

[Read More]

Mark Carges joins Veeva Board of Directors

Friday, June 23, 2017

Veeva Systems announced the appointment of Mark Carges to the company’s Board of Directors. Carges brings deep development and operational experience to Veeva’s board, having built some of the most impactful and widely-used consumer and enterprise software platforms.

[Read More]

Survey: Global clinical operations need to unify clinical applications

Wednesday, June 21, 2017

There is an industry-wide drive toward a unified clinical operating model, according to the Veeva 2017 Unified Clinical Operations Survey, one of the industry’s largest annual surveys of clinical operations professionals. The new research from Veeva Systems reveals that nearly all respondents cite the need to unify their clinical applications, including EDC, CTMS and eTMF. More than 60% say faster study execution and improved study quality are the top drivers toward a unified clinical model, which is characterized by end-to-end processes and systems, visibility across the clinical life cycle and modern information systems.

[Read More]

Veeva launches Vault SiteExchange for simple clinical trial document exchange

Thursday, April 20, 2017

Veeva Systems announced Veeva Vault SiteExchange, a cloud application that allows life sciences companies, CROs and sites to easily access and exchange information during clinical trial execution. Veeva Vault SiteExchange streamlines collaboration among clinical teams for improved visibility across studies and increased operational efficiency to speed the research and development of new treatments.

[Read More]

Three Questions: Dawn M. Furey, Merck & Co.

Tuesday, February 21, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Barbara M. Bolten spoke with Dawn M. Furey, executive director, head of Global Operations, Global Clinical Trial Operations, Merck & Co. Furey leads the global alignment of strategies for implementation of clinical trial operations with a focus on trial feasibility and allocation, trial site documentation, enrollment/retention planning and support of project delivery. She also led the implementation of a cloud-based electronic trial master file solution, Veeva Vault eTMF.

[Read More]